NO154751C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme hydroksykarbonylfosfonsyreestere. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme hydroksykarbonylfosfonsyreestere.

Info

Publication number
NO154751C
NO154751C NO784330A NO784330A NO154751C NO 154751 C NO154751 C NO 154751C NO 784330 A NO784330 A NO 784330A NO 784330 A NO784330 A NO 784330A NO 154751 C NO154751 C NO 154751C
Authority
NO
Norway
Prior art keywords
hydroxycarbonyl
preparation
therapeutically effective
acid esters
phosphonic acid
Prior art date
Application number
NO784330A
Other languages
English (en)
Other versions
NO154751B (no
NO784330L (no
Inventor
Aake John Erik Helgstrand
Karl Nils-Gunnar Johansson
Alfons Misiorny
Jan-Olof Noren
Goeran Bertil Stening
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of NO784330L publication Critical patent/NO784330L/no
Publication of NO154751B publication Critical patent/NO154751B/no
Publication of NO154751C publication Critical patent/NO154751C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4062—Esters of acids containing the structure -C(=X)-P(=X)(XR)2 or NC-P(=X)(XR)2, (X = O, S, Se)
    • C07F9/4065—Esters of acids containing the structure -C(=X)-P(=X)(XR)2, (X = O, S, Se)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO784330A 1977-12-22 1978-12-21 Analogifremgangsmaate for fremstilling av terapeutisk virksomme hydroksykarbonylfosfonsyreestere. NO154751C (no)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB5358077 1977-12-22
GB5358177 1977-12-22
GB5358277 1977-12-22
GB5358377 1977-12-22
GB7828553 1978-07-03
GB7828548 1978-07-03
GB7828555 1978-07-03
GB7828552 1978-07-03

Publications (3)

Publication Number Publication Date
NO784330L NO784330L (no) 1979-06-25
NO154751B NO154751B (no) 1986-09-08
NO154751C true NO154751C (no) 1986-12-17

Family

ID=27571200

Family Applications (2)

Application Number Title Priority Date Filing Date
NO784331A NO156611C (no) 1977-12-22 1978-12-21 Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO784330A NO154751C (no) 1977-12-22 1978-12-21 Analogifremgangsmaate for fremstilling av terapeutisk virksomme hydroksykarbonylfosfonsyreestere.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO784331A NO156611C (no) 1977-12-22 1978-12-21 Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.

Country Status (14)

Country Link
US (4) US4386081A (no)
EP (2) EP0003275B1 (no)
JP (2) JPS54109951A (no)
AT (1) AT369017B (no)
AU (1) AU530031B2 (no)
CA (2) CA1144937A (no)
DE (2) DE2861045D1 (no)
DK (2) DK148631C (no)
FI (2) FI68626C (no)
HK (1) HK33584A (no)
IE (1) IE48011B1 (no)
MY (1) MY8500058A (no)
NO (2) NO156611C (no)
SG (1) SG82383G (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1144937A (en) * 1977-12-22 1983-04-19 Dke J.E. Helgstrand Aromatic derivatives, pharmaceutical compositions and methods for combatting virus infections
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5166386A (en) * 1989-09-18 1992-11-24 E. R. Squibb & Sons, Inc. Process of making isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5025003A (en) * 1989-09-18 1991-06-18 E. R. Squibb & Sons, Inc. Isoprenoid phosphinylformic acid squalene synthetase inhibitors
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US5132414A (en) * 1990-05-10 1992-07-21 Dana-Farber Cancer Institute, Inc. Dideoxynucleoside-5'-phosphonoformic acid compounds
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
US6096730A (en) * 1997-07-24 2000-08-01 University Of Kentucky Research Foundation Phosphonated agents and their antiangiogenic and antitumorigenic use
IL134619A0 (en) * 1997-08-18 2001-04-30 Univ Kingston Phosphono-carboxylate compounds for treating amyloidosis
US5869469A (en) * 1997-08-18 1999-02-09 Queen's University At Kingston Phosphonocarboxylate compounds for treating amyloidosis
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
NZ550199A (en) * 1998-02-11 2008-07-31 Bellus Health Int Ltd Treatment of inflammation, abeta-induced cell toxicity, neuronal cell death or neuronal cell loss in subjects suffering from alzheimer's disease
US6329356B1 (en) 1998-04-10 2001-12-11 Neurochem, Inc. Phosphono-carboxylate compounds for treating amyloidosis
US6310073B1 (en) * 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
WO2000064420A2 (en) * 1999-04-28 2000-11-02 Queen's University At Kingston Compositions and methods for treating amyloidosis using sulphonate derivatives
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US6670399B2 (en) * 1999-12-23 2003-12-30 Neurochem (International) Limited Compounds and methods for modulating cerebral amyloid angiopathy
WO2003082848A1 (en) * 2002-04-01 2003-10-09 Pfizer Inc. Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
DOP2003000641A (es) * 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en) * 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
US20040214178A1 (en) * 2003-04-24 2004-10-28 Agouron Pharmaceuticals, Inc. Reporter-selectable Hepatitis C virus replicon
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
EP1781662B1 (en) * 2004-08-18 2011-04-20 Pfizer, Inc. Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
ITMI20041822A1 (it) * 2004-09-24 2004-12-24 Pharmaproducts Uk Ltd "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"
JP2008520647A (ja) * 2004-11-16 2008-06-19 ニューロケム （インターナショナル） リミテッド Ｃｎｓおよびアミロイド関連疾患治療のための化合物
CA2900876A1 (en) 2004-12-22 2006-08-17 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
AU2006342958A1 (en) * 2005-12-22 2007-11-08 Bellus Health (International) Limited Treatment of renal disorders, diabetic nephropathy and dyslipidemias
WO2009019534A2 (en) 2006-10-12 2009-02-12 Bellus Health (International) Limited Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
EP2120905A1 (en) * 2006-12-22 2009-11-25 BELLUS Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
US20080293648A1 (en) * 2007-01-05 2008-11-27 Saha Pharmaceuticals, Inc. Compositions and Methods for Cancer Treatment
DE102012103717A1 (de) * 2012-04-27 2013-11-14 Westfälische Wilhelms-Universität Münster Arzneimittel zur Behandlung von Tumorerkrankungen
EP3086397B1 (en) * 2013-12-19 2018-10-10 Ube Industries, Ltd. Nonaqueous electrolyte solution, electricity storage device using same, and phosphonoformic acid compound used in same
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
CN109400645A (zh) * 2017-08-18 2019-03-01 四川海思科制药有限公司 一种磷酸衍生物及制备方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155597A (en) * 1961-06-23 1964-11-03 Monsanto Co Extractive separation process
CH513590A (de) 1968-05-24 1971-10-15 Du Pont Carbamoylphosphonat enthaltender Pflanzenwachstumsregler
US3997544A (en) * 1968-05-24 1976-12-14 E. I. Du Pont De Nemours And Company Plant growth regulant carbamoylphosphonates
US3846512A (en) * 1968-05-24 1974-11-05 Du Pont Carbamoylphosphonates
US3533995A (en) * 1968-08-27 1970-10-13 Fmc Corp Heat stabilization of polyester resin with alkyl dialkoxyphosphinyl formate
GB1317768A (en) 1969-08-14 1973-05-23 Du Pont Plant growth regulants
US3849102A (en) * 1969-08-14 1974-11-19 Du Pont Plant growth regulant method
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
US3943201A (en) * 1973-07-23 1976-03-09 E. I. Du Pont De Nemours And Comapny Alkoxy carboxycarbonylphosphonic acid esters
BR7405998D0 (pt) * 1973-07-23 1975-05-13 Du Pont Processos compostos e composicoes para controlar o crescimmento de plantas
US4017297A (en) * 1975-08-29 1977-04-12 E. I. Du Pont De Nemours And Company Phosphonates for the control of bindweed
US4052439A (en) * 1976-04-30 1977-10-04 Abbott Laboratories Carboxylic esters of phosphonoacetic acid
US4092412A (en) * 1976-04-30 1978-05-30 Abbott Laboratories Treatment of herpes simplex infections
CA1069526A (en) * 1976-04-30 1980-01-08 Thomas R. Herrin Phosphorus esters of phosphonoacetic acid
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
CA1144937A (en) * 1977-12-22 1983-04-19 Dke J.E. Helgstrand Aromatic derivatives, pharmaceutical compositions and methods for combatting virus infections

Also Published As

Publication number Publication date
JPS54109951A (en) 1979-08-29
AU530031B2 (en) 1983-06-30
ATA921778A (de) 1982-04-15
AT369017B (de) 1982-11-25
FI783932A (fi) 1979-06-23
NO154751B (no) 1986-09-08
EP0003007A3 (en) 1979-08-08
US4591583A (en) 1986-05-27
EP0003007A2 (en) 1979-07-11
US4372894A (en) 1983-02-08
US4386081A (en) 1983-05-31
US4536400A (en) 1985-08-20
FI65438C (fi) 1984-05-10
NO784331L (no) 1979-06-25
DK148632C (da) 1986-03-03
MY8500058A (en) 1985-12-31
DK564178A (da) 1979-06-23
NO784330L (no) 1979-06-25
DK564278A (da) 1979-06-23
FI65438B (fi) 1984-01-31
FI68626C (fi) 1985-10-10
HK33584A (en) 1984-04-27
IE48011B1 (en) 1984-09-05
JPS6330885B2 (no) 1988-06-21
AU4268278A (en) 1979-06-28
NO156611C (no) 1987-10-21
NO156611B (no) 1987-07-13
JPS6254118B2 (no) 1987-11-13
EP0003275A1 (en) 1979-08-08
CA1144937A (en) 1983-04-19
IE782493L (en) 1979-06-22
EP0003275B1 (en) 1981-09-02
DK148632B (da) 1985-08-19
SG82383G (en) 1985-03-08
DK148631B (da) 1985-08-19
DE2861045D1 (en) 1981-11-26
DE2861729D1 (en) 1982-05-19
FI68626B (fi) 1985-06-28
CA1140049A (en) 1983-01-25
DK148631C (da) 1986-03-03
JPS54106431A (en) 1979-08-21
FI783931A (fi) 1979-06-23
EP0003007B1 (en) 1982-04-07

Similar Documents

Publication Publication Date Title
NO154751C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme hydroksykarbonylfosfonsyreestere.
NO144420C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme hydroksansyrer
NO784397L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater
NO142034C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoletere.
NO154058C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer.
NO158679C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-penem-3-karboksylsyreforbindelser.
SE7801428L (sv) Forfarande for framstellning av cefemkarbonsyror
NO161000C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktiv penemkarboksylsyre eller -ester.
NO771578L (no) Fremgangsmaate for fremstilling av di-n-propyleddiksyre
NO150605C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinyl-aminoalkyletere
SE7803853L (sv) Forfarande for framstellning av estrar av oxalsyra
NO151288C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolokinolizindiner
NO780777L (no) Fremgangsmaate ved fremstilling av 1-azaxanthon-3-carboxylsyrer
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NO781879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO780785L (no) Fremgangsmaate for fremstilling av optisk aktive 2-arylpropionsyrer
DK156953C (da) Fremgangsmaade til fremstilling af phenylglyoxylsyreestere
BR7800822A (pt) Process for the preparation of new esters
NO149314C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive imidazoisokinolindioner
NO147483C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner.
NO152451C (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
NO141716C (no) Fremgangsmaate for fremstilling av tiokarbaminsyreestere
SE7607026L (sv) Forfarande for framstellning av 5-alkylpikolinsyra
NO142839C (no) Analogifremgangmsmaate for fremstilling av terapeutisk aktive triazolo-tieno-diazepinderivater
DK142577C (da) Analogifremgangsmaade til fremstilling af n-pyrimidinyl-imidsyreestere